Deutsche Bank’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-128,895
| Closed | -$17.6M | – | 5730 |
|
|
2018
Q2 | $17.6M | Buy |
128,895
+62,715
| +95% | +$5.7M | 0.01% | 1271 |
|
|
2018
Q1 | $5.21M | Buy |
66,180
+33,596
| +103% | +$2.48M | ﹤0.01% | 2179 |
|
|
2017
Q4 | $2.22M | Sell |
32,584
-1,641
| -5% | -$85.1K | ﹤0.01% | 2649 |
|
|
2017
Q3 | $1.37M | Buy |
34,225
+10,846
| +46% | +$419K | ﹤0.01% | 2792 |
|
|
2017
Q2 | $928K | Buy |
23,379
+20,054
| +603% | +$734K | ﹤0.01% | 3081 |
|
|
2017
Q1 | $106K | Sell |
3,325
-5,187
| -61% | -$129K | ﹤0.01% | 3891 |
|
|
2016
Q4 | $149K | Sell |
8,512
-2,188
| -20% | -$47.1K | ﹤0.01% | 3849 |
|
|
2016
Q3 | $248K | Buy |
10,700
+691
| +7% | +$15.7K | ﹤0.01% | 3549 |
|
|
2016
Q2 | $186K | Sell |
10,009
-2,908
| -23% | -$52.6K | ﹤0.01% | 3818 |
|
|
2016
Q1 | $233K | Buy |
12,917
+240
| +2% | +$3.87K | ﹤0.01% | 3588 |
|
|
2015
Q4 | $266K | Sell |
12,677
-5,825
| -31% | -$112K | ﹤0.01% | 3576 |
|
|
2015
Q3 | $338K | Sell |
18,502
-16,364
| -47% | -$409K | ﹤0.01% | 3569 |
|
|
2015
Q2 | $1.18M | Buy |
34,866
+8,492
| +32% | +$342K | ﹤0.01% | 2859 |
|
|
2015
Q1 | $1.27M | Sell |
26,374
-1,501
| -5% | -$68.1K | ﹤0.01% | 2743 |
|
|
2014
Q4 | $617K | Buy |
27,875
+20,605
| +283% | +$475K | ﹤0.01% | 3537 |
|
|
2014
Q3 | $136K | Buy |
7,270
+386
| +6% | +$9.21K | ﹤0.01% | 4314 |
|
|
2014
Q2 | $185K | Buy |
6,884
+546
| +9% | +$13.8K | ﹤0.01% | 4174 |
|
|
2014
Q1 | $204K | Buy |
6,338
+1,844
| +41% | +$59.9K | ﹤0.01% | 3883 |
|
|
2013
Q4 | $106K | Buy |
+4,494
| New | +$126K | ﹤0.01% | 4027 |
|
Deutsche Bank's FMI Position: Q3 2018 in Review
Deutsche Bank sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 128,895 shares — an estimated $17.6M sold.
Deutsche Bank first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $17.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Deutsche Bank reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Deutsche Bank sold 128,895 Foundation Medicine, Inc. shares in Q3 2018, an estimated $17.6M.
- Deutsche Bank first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Deutsche Bank's Foundation Medicine, Inc. position peaked at $17.6M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.